An ongoing dialogue on HIV/AIDS, infectious diseases,
March 1st, 2009
Sedation for Colonoscopies in HIV Patients: Debate Rages
Here’s a problem we’re grappling with:
A patient with HIV needs a colonoscopy, but is on either a ritonavir-boosted protease inhibitor or an efavirenz-based regimen.
(This must be something like 90% of HIV patients as of March 1, 2009, based on my extremely unscientific gut impression.)
For efavirenz, midazolam is contraindicated; for ritonavir, same story — or “consider therapy modification”, according to one source I found. Ditto fentanyl.
So what should be given for sedation? (Important side note: if you told me pre-1996 that this would be a critical management question for my HIV patients, I would have thought you were out of your mind.)
Lots of different views here in Boston, including:
- Give the usual meds, titrate to effect
- NEVER give midazolam with either efavirenz or ritonavir; instead, use lorazepam, etc
- Stop HIV meds 1 day in advance, then give midazolam and fentanyl
Does anyone know? Or does anyone have sufficient experience to share?
Categories: Antiretroviral Rounds, HIV, Patient Care
Tags: colonoscopy, fentanyl, HIV, hiv patients, lorazepam, midazolam, protease, protease inhibitor, titrate
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
4 Responses to “Sedation for Colonoscopies in HIV Patients: Debate Rages”

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
- When AI Gets the Medical Advice Wrong — and Right
- How the Z-Pak Took Over Outpatient Medicine
- Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease
- Influenza — So Familiar, Still So Mysterious
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country
-
From the Blog — Most Recent Articles
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country January 27, 2026
- Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease January 21, 2026
- Influenza — So Familiar, Still So Mysterious January 14, 2026
- How the Z-Pak Took Over Outpatient Medicine, Part 2: The Reckoning January 6, 2026
FROM NEJM — Recent Infectious Disease Articles- A Pediatrician’s Dilemma — Pushing Back against CDC Guidance in the Exam Room February 7, 2026When a mother cites the CDC as her source of dangerous misinformation about vaccines, her child’s pediatrician struggles: how hard can a doctor push back without destroying the trust built over a lifetime?
- A Matter of Time February 5, 2026A 29-year-old woman with active opioid, alcohol, benzodiazepine, tobacco, and cocaine use disorders and recent intravenous drug use presented with acute onset of chills and increased pain and drainage of chronic wounds in both legs.
- Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season February 4, 2026Both viral and host factors have contributed to the intensity of influenza activity during the 2025–2026 season. Some of these factors can be managed, whereas others are largely beyond human control.
- Case 4-2026: An 80-Year-Old Woman with Cough and Hypoxemia January 29, 2026An 80-year-old woman was admitted to the hospital because of cough and hypoxemia (oxygen saturation, 83%). CT of the chest showed diffuse ground-glass opacities in both lungs. A diagnosis was made.
- The Essential Role of States in Protecting Immunization Access January 29, 2026In the face of U.S. federal policy shifts that threaten to destabilize vaccine access and weaken clinical guidance, states can step in and protect their residents.
- A Pediatrician’s Dilemma — Pushing Back against CDC Guidance in the Exam Room February 7, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster

I would titrate to effect. After all, we use fentanyl patches in patients on efavirenz. You just start at a lower dose.
Paul, I would sedate as usual as it has been my experience (hundreds of cases of endoscopy in patients on these meds) that there are no significant adverse effects, and there are no cases of clinically relevant drug interactions using fentanyl/midazolam for conscious sedation in patients on these agents (thousands of cases). Until it is a clinical relevant interaction (vs pharmacological or theoretical effect as it is at this time), deviating from a safe and time-tested sedation strategy for endoscopy does not seem justified.
Brian, many thanks for your input — will share with our colleagues.
Paul
[…] HIV-Infected Endoscopy Patients Posted by M. Brian Fennerty on March 14th, 2009 In a recent blog post, ID expert Paul Sax raised the question of which sedatives should be used when scoping HIV-infected […]